Cardiometabolic risk in polycystic ovary syndrome
- PMID: 29844207
- PMCID: PMC6026886
- DOI: 10.1530/EC-18-0129
Cardiometabolic risk in polycystic ovary syndrome
Abstract
Polycystic ovary syndrome (PCOS) is a common disorder in women of reproductive age. Besides hyperandrogenism, oligomenorrhea and fertility issues, it is associated with a high prevalence of metabolic disorders and cardiovascular risk factors. Several genetic polymorphisms have been identified for possible associations with cardiometabolic derangements in PCOS. Different PCOS phenotypes differ significantly in their cardiometabolic risk, which worsens with severity of androgen excess. Due to methodological difficulties, longer time-scale data about cardiovascular morbidity and mortality in PCOS and about possible beneficial effects of different treatment interventions is missing leaving many issues regarding cardiovascular risk unresolved.
Keywords: PCOS; cardiometabolic risk; cardiovascular risk; hyperandrogenism; obesity.
© 2018 The authors.
References
-
- Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED, Bartzis MI. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. Journal of Clinical Endocrinology and Metabolism 1999. 84 4006–4011. (10.1210/jcem.84.11.6148) - DOI - PubMed
-
- Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction 2004. 19 41–47. - PubMed
-
- Zawadski J, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In Polycystic Ovary Syndrome, pp 377–384. Eds Dunaif A, Givens HR, Haseltine FP. & Merriam G. Boston, MA, USA: Blackwell Scientific, 1992.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
